BR0210429A - Circovìrus atenuado - Google Patents

Circovìrus atenuado

Info

Publication number
BR0210429A
BR0210429A BR0210429-6A BR0210429A BR0210429A BR 0210429 A BR0210429 A BR 0210429A BR 0210429 A BR0210429 A BR 0210429A BR 0210429 A BR0210429 A BR 0210429A
Authority
BR
Brazil
Prior art keywords
circovirus
attenuated circovirus
attenuated
mutation
animal
Prior art date
Application number
BR0210429-6A
Other languages
English (en)
Inventor
Glenn Francis Browning
Michelle Alma Paters
Kelly Ann Tivendale
Peter Christopher Scott
Hayley Kay Brown
Brendan Scott Crabb
Original Assignee
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Melbourne filed Critical Univ Melbourne
Publication of BR0210429A publication Critical patent/BR0210429A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"CIRCOVìRUS ATENUADO". Um circovírus isolado atenuado tendo uma mutação no ácido nucléico viral que codifica a proteína viral 2 (VP2). O circovírus atenuado é particularmente adequado para uso na transferência de imunidade em um animal, particularmente pássaros.
BR0210429-6A 2001-06-14 2002-06-14 Circovìrus atenuado BR0210429A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR5674A AUPR567401A0 (en) 2001-06-14 2001-06-14 Circovirus vaccines
PCT/AU2002/000787 WO2002102999A1 (en) 2001-06-14 2002-06-14 Attenuated circovirus

Publications (1)

Publication Number Publication Date
BR0210429A true BR0210429A (pt) 2004-10-13

Family

ID=3829647

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210429-6A BR0210429A (pt) 2001-06-14 2002-06-14 Circovìrus atenuado

Country Status (10)

Country Link
US (1) US7442378B2 (pt)
EP (1) EP1407007B1 (pt)
JP (1) JP4481637B2 (pt)
CN (1) CN100547070C (pt)
AT (1) ATE444354T1 (pt)
AU (2) AUPR567401A0 (pt)
BR (1) BR0210429A (pt)
DE (1) DE60233875D1 (pt)
ES (1) ES2334646T3 (pt)
WO (1) WO2002102999A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US20040062775A1 (en) 1997-12-05 2004-04-01 Agence Francaise De Securite Sanitaire Des Aliments Circovirus sequences associated with piglet weight loss disease (PWD)
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
AU2006285850A1 (en) * 2005-08-29 2007-03-08 Japan Science And Technology Agency Antibody produced using ostrich and method for production thereof
WO2007072916A1 (ja) * 2005-12-22 2007-06-28 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 卵内接種用ワクチン
WO2008127279A2 (en) * 2006-10-05 2008-10-23 Cerebus Biologicals, Inc. Methods for treating, preventing and diagnosing porcine ttv infection
AU2008261604B2 (en) * 2007-06-13 2012-05-24 Australian Poultry Crc Pty Ltd Modulating production traits in avians
JP6821429B2 (ja) 2013-09-25 2021-01-27 ゾエティス・サービシーズ・エルエルシー Ｐｃｖ２ｂ分岐ワクチン組成物及び使用方法
CN106018302A (zh) * 2016-07-04 2016-10-12 云南农业大学 莴苣在丝核菌毒素定性和定量检测中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981502A (en) * 1990-09-12 1999-11-09 Leadd B.V. Methods and compositions for inducing apoptosis in tumor cells
NL9301272A (nl) * 1993-07-20 1995-02-16 Aesculaap Bv Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus.
ZA918426B (en) 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
US5789567A (en) * 1994-07-06 1998-08-04 Cornell Research Foundation, Inc. Chicken infectious anemia virus vaccine
GB9414888D0 (en) * 1994-07-23 1994-09-14 Univ Belfast Method and composition
CA2221570A1 (en) * 1995-06-07 1996-12-19 Aesculaap B.V. Neutralizing conformation epitopes of chicken anemia virus

Also Published As

Publication number Publication date
JP2004535194A (ja) 2004-11-25
JP4481637B2 (ja) 2010-06-16
CN100547070C (zh) 2009-10-07
ATE444354T1 (de) 2009-10-15
WO2002102999A1 (en) 2002-12-27
AU2002315560B2 (en) 2007-04-26
US20060257424A1 (en) 2006-11-16
AUPR567401A0 (en) 2001-07-12
US7442378B2 (en) 2008-10-28
EP1407007B1 (en) 2009-09-30
CN1537162A (zh) 2004-10-13
ES2334646T3 (es) 2010-03-15
DE60233875D1 (de) 2009-11-12
EP1407007A1 (en) 2004-04-14
EP1407007A4 (en) 2005-05-18

Similar Documents

Publication Publication Date Title
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CY1118901T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
ATE297757T1 (de) Chimäre impfstoffe gegen flaviviren
ATE378403T1 (de) Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
EA200600746A1 (ru) Конструкции нуклеиновых кислот
UA84284C2 (ru) Способы лечения, профилактики и диагностики инфекции helicobacter cerdo
DK0870046T3 (da) Levende rekombinant vaccine som indeholder felint herpesvirus type 1, især til behandling af felin infektiös peritonitis
DE60233875D1 (de) Attenuierter circovirus
DE602004023757D1 (de) Methode zur reinigung von fsh
DE60139544D1 (de) Veränderte, fluoreszierende proteine
ATE332354T1 (de) Antikesselsteinreinigungsmittel
ATE442441T1 (de) Virale expressionsvektoren für pflanzen
DE60133455D1 (de) G-protein gekoppelter rezeptor
NO20020064L (no) Chlamysin B antibakterielt protein, gen som koder for dette samt et ekspresjonssystem for dette
HUP0103871A2 (hu) Rekombináns CELO-vírus és CELO vírus DNS
ATE406446T1 (de) Vermehrungsproteine von pflanzen
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
DE60135971D1 (de) Mit wt1 interagierendes protein, wtip
ES1050379Y (es) Limpiador vaginal.
ITSA20010001A0 (it) "galleggiante pasturatore sezionalbile".

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ARTIGO 10 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.